GVAG
IBB icon

Great Valley Advisor Group’s iShares Biotechnology ETF IBB Stock Holding History

Great Valley Advisor Group’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$640K Buy
3,362
+6
+0.2% +$1.03K 0.01% 640
2026
Q1 		$567K Buy
3,356
+1,171
+54% +$200K 0.01% 651
2025
Q4 		$369K Sell
2,185
-1,228
-36% -$199K 0.01% 720
2025
Q3 		$493K Sell
3,413
-349
-9% -$47.6K 0.01% 627
2025
Q2 		$475K Sell
3,762
-1,916
-34% -$235K 0.01% 614
2025
Q1 		$726K Buy
5,678
+27
+0.5% +$3.66K 0.02% 508
2024
Q4 		$747K Sell
5,651
-837
-13% -$118K 0.02% 500
2024
Q3 		$945K Sell
6,488
-2
-0% -$289 0.02% 434
2024
Q2 		$891K Sell
6,490
-6,621
-50% -$884K 0.02% 408
2024
Q1 		$1.8M Buy
13,111
+10,325
+371% +$1.41M 0.05% 292
2023
Q4 		$378K Buy
2,786
+344
+14% +$42K 0.01% 524
2023
Q3 		$299K Sell
2,442
-963
-28% -$122K 0.01% 545
2023
Q2 		$432K Sell
3,405
-411
-11% -$53.4K 0.02% 474
2023
Q1 		$493K Sell
3,816
-28
-0.7% -$3.67K 0.02% 440
2022
Q4 		$504K Buy
3,844
+214
+6% +$27.7K 0.03% 441
2022
Q3 		$424K Sell
3,630
-302
-8% -$37.5K 0.02% 458
2022
Q2 		$463K Buy
3,932
+2,300
+141% +$273K 0.03% 442
2022
Q1 		$238K Sell
1,632
-158
-9% -$20.6K 0.01% 532
2021
Q4 		$284K Sell
1,790
-1,411
-44% -$218K 0.02% 495
2021
Q3 		$518K Sell
3,201
-259
-7% -$43.6K 0.04% 349
2021
Q2 		$548K Buy
3,460
+598
+21% +$92.1K 0.04% 329
2021
Q1 		$431K Sell
2,862
-32
-1% -$5.08K 0.04% 333
2020
Q4 		$438K Buy
2,894
+243
+9% +$34.7K 0.05% 298
2020
Q3 		$359K Sell
2,651
-7
-0.3% -$950 0.04% 299
2020
Q2 		$363K Buy
2,658
+701
+36% +$89.4K 0.06% 287
2020
Q1 		$211K Hold
1,957
– – 0.06% 281
2019
Q4 		$235K Sell
1,957
-150
-7% -$16.7K 0.05% 320
2019
Q3 		$210K Sell
2,107
-164
-7% -$17.2K 0.05% 322
2019
Q2 		$248K Buy
2,271
+475
+26% +$50.5K 0.06% 283
2019
Q1 		$201K Buy
+1,796
New +$197K 0.06% 285

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Great Valley Advisor Group's IBB Position: Q2 2026 in Review

Great Valley Advisor Group increased its iShares Biotechnology ETF (IBB) stake by 0.18% in Q2 2026, buying an estimated $1.03K and bringing the position to 3,362 shares worth $640K. The position accounts for 0.01% of the portfolio, ranked #640.

Great Valley Advisor Group first reported a position in IBB in Q1 2019 and has held it in 30 quarters since. The position peaked at $1.8M in Q1 2024. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Great Valley Advisor Group held 3,362 shares of iShares Biotechnology ETF worth $640K as of Q2 2026.
  • Great Valley Advisor Group bought 6 iShares Biotechnology ETF shares in Q2 2026, an estimated $1.03K.
  • iShares Biotechnology ETF made up 0.01% of Great Valley Advisor Group's portfolio in Q2 2026, its #640 holding.
  • Great Valley Advisor Group first reported a position in iShares Biotechnology ETF in Q1 2019 and has held it in 30 quarters since.
  • Great Valley Advisor Group's iShares Biotechnology ETF position peaked at $1.8M in Q1 2024.
  • 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Great Valley Advisor Group's 13F filing for Q2 2026, filed 10 Aug 2026.